SEC Filing Analysis: REPLIGEN CORP (RGEN)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director exercised stock options, a routine transaction with a total value of approximately $88,000.
• Market Impact: The transaction is negligible relative to Repligen's $8.58 billion market capitalization and is not expected to impact the stock.

Company Information

Field	Value
Company	REPLIGEN CORP
Ticker Symbol	RGEN
CIK	0000730272
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	MUIR GLENN P
CIK	0001181190
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-16
Transaction Code	M (Exercise of Options)
Security Type	Common Stock
Shares Involved	3,366
Price Per Share	$26.12
Total Value	$87,913.92
Shares Owned After	36,622
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$87,913.92
% of Market Cap	0.001%
Shares Transacted	3,366
% of Shares Outstanding	0.006%
Post-Transaction Ownership	36,622 shares (0.065% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction's value of ~$88k is immaterial for a company with an $8.58 billion market cap.
• Ownership Concentration: The director's post-transaction ownership of 36,622 shares represents a very small fraction (0.065%) of the total shares outstanding.
• Transaction Significance: The transaction is an exercise of options, which is a common compensation event and not an open-market purchase reflecting new insider sentiment. Its size relative to both market cap and shares outstanding is negligible.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a routine, low-value option exercise that does not signal a change in the insider's outlook on the company. The transaction size is too small to have any market impact.

Volume & Sentiment

• Expected Volume Impact: None. The transaction is too small to affect trading volume.
• Sentiment Indicator: Neutral. Option exercises are generally viewed as neutral events unless followed by a significant open-market sale.

Additional Context

Transaction Notes

• The filing indicates the exercise of a stock option that was fully vested and set to expire on May 11, 2026. This is a standard execution of a long-term incentive plan.